Management, along with KOL Dr. Muntau of University Medical Center, Hamburg, Germany, will discuss the sepiapterin clinical program on a conference call to be held on July 19 at 12 pm. Webcast Link
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PTCT:
- PTC Therapeutics to host conference call
- PTC Therapeutics names Pierre Gravier as CFO
- Investors had ‘modest expectations’ for PTC’s vatiquinone, says Morgan Stanley
- Cantor trims PTC Therapeutics target to $73, says vatiquinone not core to story
- PTC study failure has minimal impact on thesis, says William Blair